Amedica Corp (AMDA) 0.65 $AMDA
Amedica Submits 510(k) Application to FDA for Composite Spinal Interbody Spacers With Porous Silicon Nitride Center
GlobeNewswire - Thu Feb 12, 7:01AM CST
Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, announced today that it has filed a submission for 510(k) clearance of the Valeo C Interbody with CsC Osteo-Conductive Scaffolding ("Valeo C"
with the U.S. Food and Drug Administration ("FDA" relating to its composite silicon nitride spinal interbody devices.
AMDA: 0.65 (+0.01)
What One Ought to Know in the Healthcare Sector: New Research on Amarin, Amedica, Amedisys, American CareSource, and AS&E
PR Newswire - Thu Feb 12, 7:00AM CST
Editor Note: For more information about this release, please scroll to bottom.
ANCI: 3.10 (-0.20), AMRN: 1.18 (unch), ASEI: 56.82 (+0.30), AMED: 28.62 (+0.16), AMDA: 0.65 (+0.01)
Amedica Corporation Announces Selection of PCG Advisory as Agency of Record
GlobeNewswire - Tue Feb 10, 8:07AM CST
Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, announced today they have engaged PCG Advisory (PCG) as their agency of record for capital markets advisory services, strategic and tactical digital and social media communications, and public relations advisory services.
AMDA: 0.65 (+0.01)
13 IPOs You Wish You Didn't Buy in 2014 (And Killed Your Portfolio)
at The Street - Fri Feb 06, 11:55AM CST
Here are the 13 worst performing IPO stocks in 2014.
ROKA: 4.04 (+0.01), SHAK: 40.69 (+0.04), BRDR: 6.15 (+0.04), ECR: 7.29 (+0.12), BIOC: 1.41 (+0.22), ATEN: 4.14 (-0.09), CRCM: 7.98 (-0.07), AMDA: 0.65 (+0.01), MOLG: 2.46 (+0.03), SGNL: 3.91 (+2.15), GBSN: 1.77 (-0.08), FMSA: 6.23 (+0.29), HELI: 2.11 (+0.03), REPH: 3.13 (-0.12)
Amedica Becomes First to Receive FDA Clearance for Two-Level Cervical Interbody Cage Indications
GlobeNewswire - Tue Feb 03, 7:01AM CST
Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, announced today that the U.S. Food and Drug Administration (FDA) has expanded the indications of Amedica's silicon nitride interbody fusion products to include multi-level cervical treatment.
AMDA: 0.65 (+0.01)
InterMed Resources and Amedica Corporation Announce Agreement With HealthTrust
GlobeNewswire - Tue Jan 20, 7:11AM CST
InterMed Resources and Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, today announced the signing of a purchase agreement with HealthTrust, a leading group purchasing and total cost management organization that serves nearly 1,400 acute care facilities nationwide.
AMDA: 0.65 (+0.01)
Amedica realigns organization to improve performance
Seeking Alpha - at Seeking Alpha - Mon Jan 12, 11:24AM CST
AMDA: 0.65 (+0.01)
Amedica Announces Steps to Simplify Organization and Align Financial Objectives
GlobeNewswire - Mon Jan 12, 7:00AM CST
Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, today announced the results of a comprehensive business review to improve financial performance, increase operational efficiencies, and strengthen the Company's value proposition.
AMDA: 0.65 (+0.01)
Here's the Best Way for Investors to Play the IPO Market
at The Street - Thu Jan 08, 5:10AM CST
Quick returns of 200% or more are possible on initial public offerings but taking the long broad view offers the best shot at solid returns.
RDUS: 50.37 (+0.63), FPX: 51.95 (+0.32), KWEB: 33.34 (+0.39), FB: 75.74 (-0.49), ASPX: 65.76 (+2.76), BABA: 89.05 (+1.95), AMDA: 0.65 (+0.01)
Amedica's Spinal Interbody Spacers With Porous Silicon Nitride Center Provide Equivalent Fusion to PEEK Spacers With Bone Autograft
GlobeNewswire - Mon Jan 05, 7:26AM CST
Amedica Corporation (Nasdaq:AMDA), a biomaterial company that develops and commercializes silicon nitride ceramics, today released the results of its CASCADE study, a blinded, randomized clinical trial that compared outcomes of spinal fusion surgery between its composite silicon nitride spacers manufactured with a central core of cancellous structured ceramic (CsC), to the gold standard, i.e., PEEK (polyether ether ketone plastic) spacers filled with bone autograft.
AMDA: 0.65 (+0.01)
Amedica provides business update
Seeking Alpha - at Seeking Alpha - Thu Dec 18, 9:51AM CST
AMDA: 0.65 (+0.01)
Amedica Announces Preliminary Q4 & FY 2014 Financial Results and Update on CASCADE Clinical Study
GlobeNewswire - Thu Dec 18, 7:10AM CST
Amedica Corporation (Nasdaq:AMDA), a biomaterial company that has developed silicon nitride ceramics as a material platform to manufacture and commercialize orthopaedic implants, today announced that it expects to report full-year 2014 revenue in the range of $22 million and $24 million. These preliminary, unaudited financial results for the year ending December 31, 2014 are based on current expectations and are subject to quarter-end closing adjustments, actual results may differ.
AMDA: 0.65 (+0.01)
Amedica Corporation Closes Public Offering
GlobeNewswire - Mon Dec 08, 7:17AM CST
Amedica Corporation (Nasdaq:AMDA), a biomaterial company that has developed silicon nitride ceramics as a material platform to manufacture and commercialize orthopaedic implants, announced today that it has closed the previously announced firm commitment underwritten public offering of units on November 26, 2014. Amedica issued 11,441,646 units at a price to the public of $1.14 per unit. Each unit consisted of one share of Amedica common stock and one warrant to purchase one share of common stock. In addition, Amedica issued an additional 1,716,246 warrants (each such warrant to purchase one share of common stock) pursuant to the exercise, in part, of the underwriters' over-allotment option. Gross proceeds to Amedica were approximately $13.0 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by Amedica. The warrants have an exercise price of $1.48 per share, may be exercised on a cashless basis and will expire five years from the date of issuance.
AMDA: 0.65 (+0.01)
Nasdaq stocks posting largest volume increases
AP - Fri Nov 21, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
HBCP: 21.42 (unch), TCPC: 16.39 (+0.17), CZFC: 12.30 (-0.03), AMDA: 0.65 (+0.01)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Nov 21, 11:46AM CST
LEJU: 10.88 (+0.48), GEOS: 19.15 (+0.02), LXRX: 0.89 (unch), OTIV: 1.75 (unch), GME: 37.35 (+0.10), ARUN: 17.70 (-0.01), NBS: 3.78 (+0.14), PHMD: 1.68 (+0.04), AMDA: 0.65 (+0.01), CANF: 3.85 (+0.05), MOLG: 2.46 (+0.03), WAIR: 14.32 (+0.30), EDAP: 3.55 (+0.13), FWM: 5.55 (+0.08), GERN: 3.03 (unch), OCRX: 6.27 (-0.16), NGVC: 30.28 (+0.45), SFUN: 6.74 (-0.01), EJ: 7.44 (+0.01), BGI: 1.41 (-0.05)
Premarket Gainers / Losers as of 9:10 am
Seeking Alpha - at Seeking Alpha - Fri Nov 21, 8:13AM CST
NETE: 1.29 (+0.14), ANV: 0.97 (-0.03), EXXI: 4.00 (+0.42), LXRX: 0.89 (unch), OTIV: 1.75 (unch), GME: 37.35 (+0.10), ARUN: 17.70 (-0.01), GFI: 4.83 (-0.21), CLF: 7.00 (+0.35), NYMT: 7.75 (+0.05), AMDA: 0.65 (+0.01), MOLG: 2.46 (+0.03), SID: 1.76 (+0.06), SCTY: 57.60 (+0.44), VALE: 8.05 (+0.32), SFUN: 6.74 (-0.01), GOL: 3.85 (+0.01), SPLK: 64.18 (+2.25), ICLD: 2.87 (+0.11), BBL: 48.82 (+2.36), ROST: 96.18 (+0.51)
Amedica prices offering
Seeking Alpha - at Seeking Alpha - Fri Nov 21, 7:28AM CST
AMDA: 0.65 (+0.01)
Amedica Corporation Prices Public Offering
GlobeNewswire - Fri Nov 21, 7:07AM CST
Amedica Corporation (Nasdaq:AMDA), a biomaterial company that has developed silicon nitride ceramics as a material platform to manufacture and commercialize orthopedic implants, announced today that it has priced a firm commitment underwritten public offering of 11,441,646 units at a price to the public of $1.14 per unit for gross proceeds of approximately $13.0 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by Amedica. Each unit consists of one share of Amedica common stock and one warrant to purchase one share of common stock. The warrants have an exercise price of $1.48 per share, may be exercised on a cashless basis and will expire five years from the date of issuance. In addition, Amedica has granted the underwriters a 45-day option to purchase up to 1,716,246 additional shares of common stock, and/or 1,716,246 additional warrants, or any combination thereof, solely to cover over-allotments, if any. The offering is expected to close on or about November 26, 2014, subject to customary closing conditions.
AMDA: 0.65 (+0.01)
Amedica Corporation Announces Multi-Year OEM Agreement With Spinal Kinetics
GlobeNewswire - Tue Nov 11, 7:01AM CST
Amedica Corporation (Nasdaq:AMDA), a biomaterial company that has developed silicon nitride ceramics as a material platform to manufacture and commercialize orthopedic implants, is pleased to announce that it has entered into a multi-year original equipment manufacturer (OEM) agreement with Spinal Kinetics, a leading innovator of advanced spinal implant technologies.
AMDA: 0.65 (+0.01)
Amedica Submits 510(k) Application to FDA for Composite Spinal Interbody Spacers With Porous Silicon Nitride Center
GlobeNewswire - Thu Feb 12, 7:01AM CST
Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, announced today that it has filed a submission for 510(k) clearance of the Valeo C Interbody with CsC Osteo-Conductive Scaffolding ("Valeo C"
with the U.S. Food and Drug Administration ("FDA" relating to its composite silicon nitride spinal interbody devices. AMDA: 0.65 (+0.01)
What One Ought to Know in the Healthcare Sector: New Research on Amarin, Amedica, Amedisys, American CareSource, and AS&E
PR Newswire - Thu Feb 12, 7:00AM CST
Editor Note: For more information about this release, please scroll to bottom.
ANCI: 3.10 (-0.20), AMRN: 1.18 (unch), ASEI: 56.82 (+0.30), AMED: 28.62 (+0.16), AMDA: 0.65 (+0.01)
Amedica Corporation Announces Selection of PCG Advisory as Agency of Record
GlobeNewswire - Tue Feb 10, 8:07AM CST
Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, announced today they have engaged PCG Advisory (PCG) as their agency of record for capital markets advisory services, strategic and tactical digital and social media communications, and public relations advisory services.
AMDA: 0.65 (+0.01)
13 IPOs You Wish You Didn't Buy in 2014 (And Killed Your Portfolio)
at The Street - Fri Feb 06, 11:55AM CST
Here are the 13 worst performing IPO stocks in 2014.
ROKA: 4.04 (+0.01), SHAK: 40.69 (+0.04), BRDR: 6.15 (+0.04), ECR: 7.29 (+0.12), BIOC: 1.41 (+0.22), ATEN: 4.14 (-0.09), CRCM: 7.98 (-0.07), AMDA: 0.65 (+0.01), MOLG: 2.46 (+0.03), SGNL: 3.91 (+2.15), GBSN: 1.77 (-0.08), FMSA: 6.23 (+0.29), HELI: 2.11 (+0.03), REPH: 3.13 (-0.12)
Amedica Becomes First to Receive FDA Clearance for Two-Level Cervical Interbody Cage Indications
GlobeNewswire - Tue Feb 03, 7:01AM CST
Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, announced today that the U.S. Food and Drug Administration (FDA) has expanded the indications of Amedica's silicon nitride interbody fusion products to include multi-level cervical treatment.
AMDA: 0.65 (+0.01)
InterMed Resources and Amedica Corporation Announce Agreement With HealthTrust
GlobeNewswire - Tue Jan 20, 7:11AM CST
InterMed Resources and Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, today announced the signing of a purchase agreement with HealthTrust, a leading group purchasing and total cost management organization that serves nearly 1,400 acute care facilities nationwide.
AMDA: 0.65 (+0.01)
Amedica realigns organization to improve performance
Seeking Alpha - at Seeking Alpha - Mon Jan 12, 11:24AM CST
AMDA: 0.65 (+0.01)
Amedica Announces Steps to Simplify Organization and Align Financial Objectives
GlobeNewswire - Mon Jan 12, 7:00AM CST
Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, today announced the results of a comprehensive business review to improve financial performance, increase operational efficiencies, and strengthen the Company's value proposition.
AMDA: 0.65 (+0.01)
Here's the Best Way for Investors to Play the IPO Market
at The Street - Thu Jan 08, 5:10AM CST
Quick returns of 200% or more are possible on initial public offerings but taking the long broad view offers the best shot at solid returns.
RDUS: 50.37 (+0.63), FPX: 51.95 (+0.32), KWEB: 33.34 (+0.39), FB: 75.74 (-0.49), ASPX: 65.76 (+2.76), BABA: 89.05 (+1.95), AMDA: 0.65 (+0.01)
Amedica's Spinal Interbody Spacers With Porous Silicon Nitride Center Provide Equivalent Fusion to PEEK Spacers With Bone Autograft
GlobeNewswire - Mon Jan 05, 7:26AM CST
Amedica Corporation (Nasdaq:AMDA), a biomaterial company that develops and commercializes silicon nitride ceramics, today released the results of its CASCADE study, a blinded, randomized clinical trial that compared outcomes of spinal fusion surgery between its composite silicon nitride spacers manufactured with a central core of cancellous structured ceramic (CsC), to the gold standard, i.e., PEEK (polyether ether ketone plastic) spacers filled with bone autograft.
AMDA: 0.65 (+0.01)
Amedica provides business update
Seeking Alpha - at Seeking Alpha - Thu Dec 18, 9:51AM CST
AMDA: 0.65 (+0.01)
Amedica Announces Preliminary Q4 & FY 2014 Financial Results and Update on CASCADE Clinical Study
GlobeNewswire - Thu Dec 18, 7:10AM CST
Amedica Corporation (Nasdaq:AMDA), a biomaterial company that has developed silicon nitride ceramics as a material platform to manufacture and commercialize orthopaedic implants, today announced that it expects to report full-year 2014 revenue in the range of $22 million and $24 million. These preliminary, unaudited financial results for the year ending December 31, 2014 are based on current expectations and are subject to quarter-end closing adjustments, actual results may differ.
AMDA: 0.65 (+0.01)
Amedica Corporation Closes Public Offering
GlobeNewswire - Mon Dec 08, 7:17AM CST
Amedica Corporation (Nasdaq:AMDA), a biomaterial company that has developed silicon nitride ceramics as a material platform to manufacture and commercialize orthopaedic implants, announced today that it has closed the previously announced firm commitment underwritten public offering of units on November 26, 2014. Amedica issued 11,441,646 units at a price to the public of $1.14 per unit. Each unit consisted of one share of Amedica common stock and one warrant to purchase one share of common stock. In addition, Amedica issued an additional 1,716,246 warrants (each such warrant to purchase one share of common stock) pursuant to the exercise, in part, of the underwriters' over-allotment option. Gross proceeds to Amedica were approximately $13.0 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by Amedica. The warrants have an exercise price of $1.48 per share, may be exercised on a cashless basis and will expire five years from the date of issuance.
AMDA: 0.65 (+0.01)
Nasdaq stocks posting largest volume increases
AP - Fri Nov 21, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
HBCP: 21.42 (unch), TCPC: 16.39 (+0.17), CZFC: 12.30 (-0.03), AMDA: 0.65 (+0.01)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Nov 21, 11:46AM CST
LEJU: 10.88 (+0.48), GEOS: 19.15 (+0.02), LXRX: 0.89 (unch), OTIV: 1.75 (unch), GME: 37.35 (+0.10), ARUN: 17.70 (-0.01), NBS: 3.78 (+0.14), PHMD: 1.68 (+0.04), AMDA: 0.65 (+0.01), CANF: 3.85 (+0.05), MOLG: 2.46 (+0.03), WAIR: 14.32 (+0.30), EDAP: 3.55 (+0.13), FWM: 5.55 (+0.08), GERN: 3.03 (unch), OCRX: 6.27 (-0.16), NGVC: 30.28 (+0.45), SFUN: 6.74 (-0.01), EJ: 7.44 (+0.01), BGI: 1.41 (-0.05)
Premarket Gainers / Losers as of 9:10 am
Seeking Alpha - at Seeking Alpha - Fri Nov 21, 8:13AM CST
NETE: 1.29 (+0.14), ANV: 0.97 (-0.03), EXXI: 4.00 (+0.42), LXRX: 0.89 (unch), OTIV: 1.75 (unch), GME: 37.35 (+0.10), ARUN: 17.70 (-0.01), GFI: 4.83 (-0.21), CLF: 7.00 (+0.35), NYMT: 7.75 (+0.05), AMDA: 0.65 (+0.01), MOLG: 2.46 (+0.03), SID: 1.76 (+0.06), SCTY: 57.60 (+0.44), VALE: 8.05 (+0.32), SFUN: 6.74 (-0.01), GOL: 3.85 (+0.01), SPLK: 64.18 (+2.25), ICLD: 2.87 (+0.11), BBL: 48.82 (+2.36), ROST: 96.18 (+0.51)
Amedica prices offering
Seeking Alpha - at Seeking Alpha - Fri Nov 21, 7:28AM CST
AMDA: 0.65 (+0.01)
Amedica Corporation Prices Public Offering
GlobeNewswire - Fri Nov 21, 7:07AM CST
Amedica Corporation (Nasdaq:AMDA), a biomaterial company that has developed silicon nitride ceramics as a material platform to manufacture and commercialize orthopedic implants, announced today that it has priced a firm commitment underwritten public offering of 11,441,646 units at a price to the public of $1.14 per unit for gross proceeds of approximately $13.0 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by Amedica. Each unit consists of one share of Amedica common stock and one warrant to purchase one share of common stock. The warrants have an exercise price of $1.48 per share, may be exercised on a cashless basis and will expire five years from the date of issuance. In addition, Amedica has granted the underwriters a 45-day option to purchase up to 1,716,246 additional shares of common stock, and/or 1,716,246 additional warrants, or any combination thereof, solely to cover over-allotments, if any. The offering is expected to close on or about November 26, 2014, subject to customary closing conditions.
AMDA: 0.65 (+0.01)
Amedica Corporation Announces Multi-Year OEM Agreement With Spinal Kinetics
GlobeNewswire - Tue Nov 11, 7:01AM CST
Amedica Corporation (Nasdaq:AMDA), a biomaterial company that has developed silicon nitride ceramics as a material platform to manufacture and commercialize orthopedic implants, is pleased to announce that it has entered into a multi-year original equipment manufacturer (OEM) agreement with Spinal Kinetics, a leading innovator of advanced spinal implant technologies.
AMDA: 0.65 (+0.01)
